Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
a study on Cirrhosis Steatohepatitis
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- Rohit Loomba, MD, MHSc.
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSD
- Rohit Loomba, MD, MHSc.
Adjunct Professor, Family Medicine and Public Health. Authored (or co-authored) 383 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Intercept Pharmaceuticals
- ID
- NCT03439254
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated